Scott Naftulin, DO
Interventional Pain Medicine · Bethlehem, PANPI 1861485369
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (58.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by International Rehabilitative Sciences, Inc at 59.4% of the total. Reporting peaked in 2023 at $3,882 and has fallen 96.5% since, to $134 in 2025.
Across 39 payments — averaging $164.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- International Rehabilitative Sciences, Inc$4K
- Vertiflex, Inc.$990
- Curonix LLC$557
- Vertos Medical, Inc.$249
- Boston Scientific$244
- SPR Therapeutics, Inc$133
- plus $424 from 9 others
What the payments were for
- Travel & lodging$1,20719%
- Food & beverage$1,43022%
- Other$3,76959%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| International Rehabilitative Sciences, Inc | 2 | $3,808 |
| Vertiflex, Inc. | 7 | $990 |
| Curonix LLC | 4 | $557 |
| Vertos Medical, Inc. | 6 | $249 |
| Boston Scientific | 5 | $244 |
| SPR Therapeutics, Inc | 1 | $133 |
| Paragon 28, Inc. | 1 | $120 |
| Si-bone, Inc. | 2 | $105 |
| Nevro Corp. | 3 | $59 |
| Electronic Waveform Lab, Inc. | 3 | $34 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Biotronik NRO, Inc. | 1 | $26 |
| MML US, Inc. | 1 | $23 |
| Medtronic | 1 | $17 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,406 in reported general payments places this provider in the 70th percentile of 59 interventional pain medicine providers in Pennsylvania.
See all interventional pain medicine providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 33 | $346 |
| Gabapentin | 46 | $261 |
| Oxycodone Hcl | 13 | $106 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Bethlehem
- Kenneth ZahlBethlehem$608
- Michael FishmanLebanon$670K
- David ProvenzanoSewickley$198K
- Michael FarrellPittsburgh$23K
- Farshad RashidianWest Chester$19K
- Chad MetzgerDarby$14K
- Jorge Rivero-BecerraPittsburgh$12K
- James BresnahanSpringfield$12K
- Jonathan SchollIndiana$11K
- Nathan MaltezosWest Chester$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.